Children Hospital of Philadelphia

3401 Civic Center Boulevard
Philadelphia, Pennsylvania 19104

We've found

2 trials

at this facility

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Philadelphia, PA

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension

Status: Enrolling, Phase III
Updated: 4/19/2018

from

Philadelphia, PA

Use our guide to learn which trials are right for you!